IHS Chemical Week

Regions :: Western Europe

Aptuit Buys Evotec’s Chemical Development Arm

8:32 AM MDT | October 3, 2007 | Alex Scott

Drug development services group Aptuit (Greenwich, CT) says it has acquired the chemical development business of drug discovery firm Evotec (Hamburg) for $64 million in cash. The acquired business comprises activities in process R&D, custom preparation, analytical development, pilot plant manufacturing, and formulation. The business has about 210 staff based at Oxford and Glasgow, U.K., and generated 2006 sales of €26.8 million ($37.2 million). “This acquisition continues Aptuit’s momentum as we assemble a complete suite of drug development...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa